multiple myeloma

KEI Comments Regarding NIH Exclusive License to Memorial Sloan Kettering Cancer Center

Posted on by Claire Cassedy

(Update: The NIH provided a response to our comments on April 15, 2021.) Knowledge Ecology International (KEI) submitted comments on April 14, 2021 to the Federal Register notice for the National Institutes of Health’s (NIH) “Prospective Grant of Exclusive Patent… Continue Reading →

FTC approves Celgene acquisition of Juno without requiring divestitures

Posted on by James Love

On Tuesday February 20, 2018, the U.S. Federal Trade Commission approved the Celgene acquisition of Juno, without requiring divestitures. The European Commission did not review the merger. KEI’s February 16, 2018 letter opposing the acquisition is available here. The following… Continue Reading →